Indolent Subtype of Kaposi's Sarcoma in HIV-Negative Patients
Author Information
Author(s): I.G. Ron, A. Kuten, N. Wigler, G. Fried, S. Nitezky, M.J. Inbar, J. Dale, S. Chaitchik
Primary Institution: Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University
Hypothesis
Is there an indolent subtype of classical disseminated Kaposi's sarcoma in HIV-negative patients?
Conclusion
The study suggests that there may be an indolent subtype of classical disseminated Kaposi's sarcoma, as evidenced by the prolonged survival of the patients.
Supporting Evidence
- Four out of five symptomatic patients became symptom-free after treatment.
- Two patients achieved complete remission.
- The 5-year survival rate for the patients was 82%.
- All patients were HIV-negative and had normal immunologic parameters.
Takeaway
Some older people can have a slow-growing type of a rare skin cancer called Kaposi's sarcoma, even if they don't have HIV.
Methodology
The study involved seven elderly Jewish patients with classical disseminated Kaposi's sarcoma, examining their clinical and immunological features.
Limitations
The study is based on a small sample size of seven patients.
Participant Demographics
All participants were elderly Jewish patients, with a male predominance (5 males and 2 females) and ages ranging from 47 to 82 years.
Want to read the original?
Access the complete publication on the publisher's website